Список проголосовавших за комментарий " Gapping up/down: ASML +5% after earnings, CLCD +33% after M&A news, JWN +1.6% after upgrade; PSO -29% and TGT -4% after earnings, DIS -1% after dg<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>NXTD</strong> +21.7%, <strong>SHLO</strong> +14%, <strong>ASML</strong> +4.9%, <strong>MHG</strong> +3.6%, <strong>FAST</strong> +0.9%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>CLCD</strong> +32.7% (to be acquired by Eli Lilly (LLY) for $46.50/share)</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>APRI</strong> +22.5% (announces that Mexico has granted the co's commercialization partner, Ferring Pharmaceuticals, market approval for Vitaros)</li><li><strong>CRNT</strong> +9.7% (announces over $60 mln in new orders so far in 2017)</li><li><strong>LIFE</strong> +8.2% (FDA grants Fast Track Designation for aTyr's Resolaris to treat limb girdle muscular dystrophy 2b and removes partial clinical hold for resolaris)</li><li><strong>JAZZ</strong> +7.3% (FDA approves first generic version of Xyrem (sodium oxybate) Oral Solution, to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy, which is a potentially debilitating disease)</li><li><strong>GPOR</strong> +2.8% (reports Q4 net production averaged 787.0 MMcfe per day, +22% Y/Y)</li><li><strong>NTNX</strong> +1.5% (following Hewlett Packard Enterprise's purchase of hyperconverged infrastructure peer SimpliVity for $650 mln in cash)</li><li><strong>QCOM</strong> +1% (says will 'vigorously contest' FTC complaint)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>EDU</strong> +3.8% (upgraded to Overweight from Neutral at JP Morgan)</li><li><strong>DECK</strong> +2.5% (upgraded to Buy from Neutral at Buckingham Research)</li><li><strong>JWN</strong> +1.6% (upgraded to Outperform from Neutral at Credit Suisse)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>PSO</strong> -28.5%, <strong>GIMO</strong> -22.2%, <strong>CCJ</strong> -10.3%, (expects adjusted net earnings for 2016 will be significantly lower than analysts' earnings estimates; announces workforce reductions)</li><li><strong>TGT</strong> -3.9%, <strong>NTRS</strong> -3.3%, <strong>CSX</strong> -2.9%, <strong>IBKR</strong> -2.8%, <strong>AMTD</strong> -0.8%, <strong>C</strong> -0.5%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>BCEI</strong> -4.3% (pulling back following y'day's move; confirms receipt of unsolicited inquiry from Bill Barrett Corporation (BBG) regarding a potential transaction between the two companies),</li></ul><p><strong>Select financial related names showing weakness</strong>:</p><ul><li><strong>CS</strong> -1.9%, <strong>BCS</strong> -1.7%, <strong>RBS</strong> -1.6%, <strong>ING</strong> -1.3%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>AFAM</strong> -5.8% (proposed underwritten public offering of 2,500,000 shares of its common stock)</li><li><strong>NBIX</strong> -4.2% ( announces the top-line results from the Company's Phase II T-Forward study of INGREZZA)</li><li><strong>TRCH</strong> -3.9% (files for 6.15 mln share common stock offering by selling shareholders)</li><li><strong>TDOC</strong> -3.2% (announced a proposed offering of shares of its common stock, which includes 5,400,000 shares offered by Teladoc and 1,850,000 shares offered by certain stockholders)</li><li><strong>KOPN</strong> -2.4% (modestly pulling back from new multi-year high made today; discloses was unable to complete its investigation and has submitted a plan to regain compliance with Nasdaq)</li><li><strong>TTPH</strong> -1.9% (entered into a Controlled Equity Offering sales agreement with Cantor to sell up to $40 mln in common stock)</li><li><strong>NSC</strong> -1.9% (in sympathy with CSX)</li><li><strong>WMT</strong> -1.2% (in sympathy with WMT)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>HIMX</strong> -3.8% (downgraded to Neutral from Outperform at Credit Suisse)</li><li><strong>KSS</strong> -2.1% (downgraded to Underperform from Neutral at Credit Suisse)</li><li><strong>JCP</strong> -1.6% (downgraded to Underperform from Neutral at Credit Suisse)</li><li><strong>DIS</strong> -0.9% (downgraded to Underperform from Market Perform at BMO Capital)</li><li><strong>XLNX</strong> -0.9% (downgraded to Underweight from Equal Weight at Barclays)</li><li><strong>MCD</strong> -0.6% (Nomura out cutting Q4 and Q1 US comps ests)</li></ul>"